January 11, 2022 DiMe Journal Club features Critical Path for Parkinson’s 3DT initiative Join 3DT and DiMe Society, January 11, to hear about 3DT recommendations for patient engagement. C-Path’s Critical Path for
C-Path’s ePRO Consortium Announces Rebranding, Changes Name to eCOA Consortium TUCSON, Ariz., January 11, 2022 — Critical Path Institute (C-Path) is pleased to announce the Electronic Patient-Report
C-Path Launches Rare Disease Clinical Outcome Assessment Consortium The Rare Disease COA Consortium aims to advance patient-focused assessment of clinical benefit in treatment trials for rare diseas
C-Path Appoints Health Outcomes Expert as Executive Director of the Rare Disease COA Consortium Dr. Lindsey Murray will lead C-Path’s New Rare Disease COA Consortium TUCSON, Ariz., January 13, 2022 — Critical Path Institut
January 19, 2022 Rare Diseases Cures Accelerator Data and Analytics Platform (RDCA-DAP) best practices and recommendations for FAIR data, toward alignment with International Regulatory agencies
C-Path and the European Joint Programme on Rare Diseases to Expand Global Impact and Partnership PARIS, France and TUCSON, Ariz., U.S., February 1, 2022 — Critical Path Institute (C-Path), an independent global nonprofit orga
April 13, 2022-April 14, 2022 13th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 13–14, 2022 On April 13–14, 2022, the 13th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual for
February 23, 2022 Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based....
eCOA Consortium Announces Publication of Open Access Article C-Path’s eCOA Consortium is pleased to announce that “Measurement Comparability of Electronic and Paper Administration of Vi
March 2, 2022 Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies